STRS Ohio’s Climb Bio CLYM Stock Holding History

STRS Ohio’s Portfolio CLYM Stock Details CLYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,300	Closed	-$6.47K	–	2325
2025 Q1	$6.47K	Hold	5,300	–	–	﹤0.01%	1891
2024 Q4	$9.54K	Hold	5,300	–	–	﹤0.01%	1848
2024 Q3	$27K	Hold	5,300	–	–	﹤0.01%	1876
2024 Q2	$37.7K	Buy	+5,300	New	+$35.3K	﹤0.01%	1828
2022 Q2	–	Sell	-1,600	Closed	-$13K	–	2332
2022 Q1	$13K	Hold	1,600	–	–	﹤0.01%	2075
2021 Q4	$16K	Hold	1,600	–	–	﹤0.01%	2139
2021 Q3	$28K	Buy	+1,600	New	+$33.1K	﹤0.01%	2156

Other funds holding CLYM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

STRS Ohio's CLYM Position: Q2 2025 in Review

STRS Ohio sold out of Climb Bio (CLYM) in Q2 2025, closing a stake of 5,300 shares — an estimated $6.47K sold.

STRS Ohio first reported a position in CLYM in Q3 2021 and held it in 7 quarters. The position peaked at $37.7K in Q2 2024. 69 funds tracked by Wall St. Rank hold CLYM as of Q2 2025.

STRS Ohio reported no remaining Climb Bio position as of Q2 2025 after selling out during the quarter.
STRS Ohio sold 5,300 Climb Bio shares in Q2 2025, an estimated $6.47K.
STRS Ohio first reported a position in Climb Bio in Q3 2021 and held it in 7 quarters.
STRS Ohio's Climb Bio position peaked at $37.7K in Q2 2024.
69 funds tracked by Wall St. Rank held Climb Bio as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.